Identification of genes and cellular response factors related to immunotherapy response in mismatch repair-proficient colorectal cancer: a bioinformatics analysis

BACKGROUND: Mismatch repair-proficient (pMMR) colorectal cancers (CRCs) are thought to be primarily resistant to immune checkpoint inhibitor (ICI) monotherapy. However, recent clinical trials have reported that early-to-mid stage (non-metastatic) CRC responds well to ICI monotherapy. We hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Wenxiu, Shi, Jinglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830321/
https://www.ncbi.nlm.nih.gov/pubmed/36636048
http://dx.doi.org/10.21037/jgo-22-1070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830321/
https://www.ncbi.nlm.nih.gov/pubmed/36636048
http://dx.doi.org/10.21037/jgo-22-1070

Ejemplares similares